Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Opioid Prescribing Guidelines From US FDA Could Be A While After NASEM Report
Dec 20 2019
•
By
Michael Cipriano
NASEM has released its report on developing opioid prescribing guidelines.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Drug Safety
More from Pink Sheet